% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Bae:140159,
author = {Bae, Eun-Jin and Kim, Dong-Kyu and Kim, Changyoun and
Mante, Michael and Adame, Anthony and Rockenstein, Edward
and Ulusoy, Ayse and Klinkenberg, Michael and Jeong, Ga Ram
and Bae, Jae Ryul and Lee, Cheolsoon and Lee, He-Jin and
Lee, Byung-Dae and Di Monte, Donato A and Masliah, Eliezer
and Lee, Seung-Jae},
title = {{LRRK}2 kinase regulates α-synuclein propagation via
{RAB}35 phosphorylation.},
journal = {Nature Communications},
volume = {9},
number = {1},
issn = {2041-1723},
address = {[London]},
publisher = {Nature Publishing Group UK},
reportid = {DZNE-2020-06481},
pages = {3465},
year = {2018},
abstract = {Propagation of α-synuclein aggregates has been suggested
as a contributing factor in Parkinson's disease (PD)
progression. However, the molecular mechanisms underlying
α-synuclein aggregation are not fully understood. Here, we
demonstrate in cell culture, nematode, and rodent models of
PD that leucine-rich repeat kinase 2 (LRRK2), a PD-linked
kinase, modulates α-synuclein propagation in a kinase
activity-dependent manner. The PD-linked G2019S mutation in
LRRK2, which increases kinase activity, enhances propagation
efficiency. Furthermore, we show that the role of LRRK2 in
α-synuclein propagation is mediated by RAB35
phosphorylation. Constitutive activation of RAB35 overrides
the reduced α-synuclein propagation phenotype in lrk-1
mutant C. elegans. Finally, in a mouse model of
synucleinopathy, administration of an LRRK2 kinase inhibitor
reduced α-synuclein aggregation via enhanced interaction of
α-synuclein with the lysosomal degradation pathway. These
results suggest that LRRK2-mediated RAB35 phosphorylation is
a potential therapeutic target for modifying disease
progression.},
keywords = {Animals / Blotting, Western / Caenorhabditis elegans:
genetics / Caenorhabditis elegans: metabolism /
Caenorhabditis elegans Proteins: genetics / Caenorhabditis
elegans Proteins: metabolism / Cell Line, Tumor / Humans /
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2:
genetics / Leucine-Rich Repeat Serine-Threonine Protein
Kinase-2: metabolism / Microscopy, Fluorescence /
Phosphorylation / Plasmids: genetics / Rats /
alpha-Synuclein: genetics / alpha-Synuclein: metabolism /
rab GTP-Binding Proteins: genetics / rab GTP-Binding
Proteins: metabolism / Caenorhabditis elegans Proteins (NLM
Chemicals) / Rab-35 protein, C elegans (NLM Chemicals) /
alpha-Synuclein (NLM Chemicals) / Leucine-Rich Repeat
Serine-Threonine Protein Kinase-2 (NLM Chemicals) / rab
GTP-Binding Proteins (NLM Chemicals)},
cin = {AG Di Monte},
ddc = {500},
cid = {I:(DE-2719)1013008},
pnm = {342 - Disease Mechanisms and Model Systems (POF3-342)},
pid = {G:(DE-HGF)POF3-342},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:30150626},
pmc = {pmc:PMC6110743},
doi = {10.1038/s41467-018-05958-z},
url = {https://pub.dzne.de/record/140159},
}